Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-03-12 @ 12:54 AM
Study NCT ID:
NCT03630094
Status:
COMPLETED
Last Update Posted:
2018-08-14
First Post:
2017-03-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Plasma and Intrapulmonary Concentrations Study of WCK 5222
Sponsor:
Wockhardt
Organization:
Study Overview
Official Title:
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 5222 (Cefepime and Zidebactam) in Healthy Adult Human Subjects
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: